This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
DFT Testing
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Study Description The purpose of this study is to compare the defibrillation efficacy between the 50/50% tilt biphasic waveform and the Tuned biphasic waveform utilizing High Voltage Lead Integrity Check (HVLIC) impedance. Hypothesis The Tuned waveform reduces defibrillation thresholds (DFTs) when compared to the 50/50% tilt waveform. Study Methods - This is an acute, paired-sample, randomized (waveform testing sequence) study - Patients are implanted with an Food and Drug Administration (FDA) approved St. Jude Medical (SJM) EpicTM+ DR/VR Implantable Cardioverter Defibrillator (or any other standard output ICD after Epic+) and defibrillation lead system. - All study testing is completed at implant. - Patients are randomized to begin DFT testing with either the 50/50% tilt or Tuned waveform. - The HVLIC feature is used to measure the high voltage lead impedance and to program the Tuned and 50/50% tilt waveform pulse widths. - The DFT is determined by an optimized binary search method that is designed to reduce the overall number of VF inductions to an average of 5.13 while maintaining very high resolution and accuracy. - Total # of centers - 15 centers - Sample size - 60 patients

Provided treatments

  • Procedure: DFT Testing with a 50/50% tilt

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01325922. The sponsor of the trial is Abbott Medical Devices and it is looking for 0 volunteers for the current phase.
Official trial title:
50/50% Tilt and Tune Defibrillation Waveforms Utilizing High Voltage Lead Integrity Check Impedance